Clinical Trial Update: A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating mezagitamab for adults with primary IgA nephropathy is currently recruiting to evaluate safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Mezagitamab (mezagitamab)

Snippet

Sponsor: Takeda | Conditions: Kidney Disease | Phase 3 | Status: RECRUITING